Brief: Cue Health Makes De Novo Submission To FDA For Full Clearance Of Its Cue® Rsv Molecular Test
09/05/2023 15:29
May 9 (Reuters) - Cue Health Inc HLTH.O :
* CUE HEALTH MAKES DE NOVO SUBMISSION TO FDA FOR FULL
CLEARANCE OF
ITS CUE® RSV MOLECULAR TEST
Source text for Eikon: ID:nBw2yCJ0Wa
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022